New research disentangles the risks for acute kidney injury related to CAR T-cell treatment in non-Hodgkin lymphoma, ...

Dr. Kara Kelly discusses the unique challenges that adolescent and young adult patients with cancer face following their ...

ChatGPT flagged serious health issues that were initially missed by doctors, leading to early detection of cancer.

In this Q&A, Carly Stafford Dixon discusses her lymphoma journey, recovery with CAR T therapy, and mission to raise support ...

Seven-year-old Afiya Khatun’s life was upended three years ago when she was diagnosed with non-Hodgkin lymphoma, a form of ...

Dr. Andrew M. Evens breaks down what it means to be an adolescent or young adult with lymphoma and how treatment differs from ...

A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory lymphoma.

Elizabeth Emory was 25 weeks pregnant when she learned she had stage four Burkitt non-Hodgkin lymphoma. “It was shocking, of ...